Skip to main content
Top
Published in: Indian Journal of Surgery 5/2023

05-12-2022 | Rectal Cancer | Original Article

Lateral Lymph Node Dissection Was Unnecessary for Low and Middle Rectal Cancer: a Systematic Review and Meta-analysis

Authors: Jiajie Zhou, Xiaoming Yuan

Published in: Indian Journal of Surgery | Issue 5/2023

Login to get access

Abstract

There was significant controversy about whether lateral lymph node dissection (LLND) should be performed routinely during radical rectal cancer surgery. This study compared total mesorectal excision (TME) with or without LLND in low and middle rectal cancer. Our team retrieved data from Pubmed, EMBASE, Ovid, Web of Science, and the Cochrane Library from their incipience to Oct 1, 2021. We combined the statistics using the survival variables’ hazard ratio (HR). If the article only provided survival curves and delivered no HR value, we used a statistical method to extract logHR and standard errors for data estimation. A total of 33 studies were included in this study (26 cohort studies and 7 randomized controlled trials (RCTs). We found a statistically significant difference in the 5-year postoperative local recurrence rate between LLND + TME group patients (HR = 1.36, 95% CI: 1.07–1.73, p = 0.01); no statistically significant difference in 5-year postoperative overall survival (OS) (HR = 0.95, 95% CI: 0.85–1.06, p = 0.36) and recurrence-free survival (RFS) (HR = 1.13, 95% CI: 0.99–1.29, p = 0.08) between patients in the LLND + TME and TME groups; no statistically significant difference in 5-year OS and RFS between the LLND + TME and TME groups, regardless of preoperative lateral lymph node metastasis (LLNM). LLND + TME was associated with significantly longer operation time (WMD 92.29, 95% CI 82.29–102.28, p < 0.00001), more intraoperative blood loss (WMD 261.31, 95% CI 196.39–326.24, p < 0.00001), higher urinary dysfunction (OR = 2.15, 95% CI 1.16–3.96, P = 0.01), and sexual dysfunction (OR = 6.33, 95% CI 1.73–23.13, P = 0.005). Whereas anastomotic leakage (OR = 1.00, 95% CI 0.54–1.85, p = 0.99) and bowel obstruction (OR = 1.03, 95% CI 0.42–2.54, p = 0.95) were similar between the two groups. LLND did not improve the long-term prognosis of patients with rectal cancer, prolonged the duration of surgery, increased intraoperative bleeding, and led to a higher incidence of postoperative voiding disorders and sexual dysfunction.
Literature
1.
go back to reference Gao X, Wang C, Yu YY, Singh D, Yang L, Zhou ZG (2020) Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. World J Surg Oncol 18(1):304 Gao X, Wang C, Yu YY, Singh D, Yang L, Zhou ZG (2020) Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. World J Surg Oncol 18(1):304
2.
go back to reference Emile SH, Elfeki H, Shalaby M, Sakr A, Kim NK (2021) Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: a systematic review and meta-analysis. Surgery 169:1005–1015CrossRefPubMed Emile SH, Elfeki H, Shalaby M, Sakr A, Kim NK (2021) Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: a systematic review and meta-analysis. Surgery 169:1005–1015CrossRefPubMed
3.
go back to reference Liu Y, Shang L, Zhou CY, Fang Z, Du FY, Wu H et al (2021) Prognostic value of lateral pelvic lymph node dissection for rectal cancer: a meta-analysis. J Surg Res 267:414–423CrossRefPubMed Liu Y, Shang L, Zhou CY, Fang Z, Du FY, Wu H et al (2021) Prognostic value of lateral pelvic lymph node dissection for rectal cancer: a meta-analysis. J Surg Res 267:414–423CrossRefPubMed
4.
go back to reference Parmar MKB, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834CrossRefPubMed Parmar MKB, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834CrossRefPubMed
5.
go back to reference Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16 Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16
7.
go back to reference Kusters M, van de Velde CJH, Beets-Tan R, Akasu T, Fujida S, Yamamoto S et al (2009) Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 16:289–296CrossRefPubMed Kusters M, van de Velde CJH, Beets-Tan R, Akasu T, Fujida S, Yamamoto S et al (2009) Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 16:289–296CrossRefPubMed
8.
go back to reference Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal-cancer surgery - the clue to pelvic recurrence. Br J Surg 69:613–616CrossRefPubMed Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal-cancer surgery - the clue to pelvic recurrence. Br J Surg 69:613–616CrossRefPubMed
9.
go back to reference Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42CrossRefPubMed Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42CrossRefPubMed
10.
go back to reference Gray R, Hills R, Stowe R, Clarke M, Peto R, Buyse M et al (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358:1291–1304CrossRef Gray R, Hills R, Stowe R, Clarke M, Peto R, Buyse M et al (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358:1291–1304CrossRef
11.
go back to reference Bosset J-F, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123CrossRefPubMed Bosset J-F, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123CrossRefPubMed
12.
go back to reference Takahashi T, Ueno M, Azekura K, Ohta H (2000) Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43:S59–S68CrossRefPubMed Takahashi T, Ueno M, Azekura K, Ohta H (2000) Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43:S59–S68CrossRefPubMed
13.
go back to reference Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K et al (2017) Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212) a multicenter, randomized controlled, noninferiority trial. Ann Surg 266:201–207CrossRefPubMed Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K et al (2017) Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212) a multicenter, randomized controlled, noninferiority trial. Ann Surg 266:201–207CrossRefPubMed
14.
go back to reference Kanemitsu Y, Komori K, Shida D, Ochiai H, Tsukamoto S, Kinoshita T et al (2017) Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: a comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery 162:303–314CrossRefPubMed Kanemitsu Y, Komori K, Shida D, Ochiai H, Tsukamoto S, Kinoshita T et al (2017) Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: a comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery 162:303–314CrossRefPubMed
15.
go back to reference Benson AB III, Venook AP, Al-Hawary MM, Arain MA, Chen Y-J, Ciombor KK et al (2020) Rectal Cancer, Version 6.2020 Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 18:807–15CrossRef Benson AB III, Venook AP, Al-Hawary MM, Arain MA, Chen Y-J, Ciombor KK et al (2020) Rectal Cancer, Version 6.2020 Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 18:807–15CrossRef
16.
go back to reference Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820CrossRefPubMedPubMedCentral Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820CrossRefPubMedPubMedCentral
17.
go back to reference Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z et al (2016) Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. J Cancer Res Clin Oncol 142:2551–2560CrossRefPubMedPubMedCentral Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z et al (2016) Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. J Cancer Res Clin Oncol 142:2551–2560CrossRefPubMedPubMedCentral
18.
go back to reference Morohashi H, Sakamoto Y, Miura T, Ichinohe D, Umemura K, Akaishi T et al (2021) Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type. Int J Colorectal Dis 36:1251–1261CrossRefPubMedPubMedCentral Morohashi H, Sakamoto Y, Miura T, Ichinohe D, Umemura K, Akaishi T et al (2021) Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type. Int J Colorectal Dis 36:1251–1261CrossRefPubMedPubMedCentral
19.
go back to reference Toritani K, Watanabe J, Suwa Y, Suzuki S, Nakagawa K, Suwa H et al (2019) The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307). Int J Colorectal Dis 34:1697–1703CrossRefPubMed Toritani K, Watanabe J, Suwa Y, Suzuki S, Nakagawa K, Suwa H et al (2019) The risk factors for urinary dysfunction after autonomic nerve-preserving rectal cancer surgery: a multicenter retrospective study at Yokohama Clinical Oncology Group (YCOG1307). Int J Colorectal Dis 34:1697–1703CrossRefPubMed
20.
go back to reference Hojo K, Vernava AM, Sugihara K, Katumata K (1991) Preservation of urine voiding and sexual function after rectal-cancer surgery. Dis Colon Rectum 34:532–539CrossRefPubMed Hojo K, Vernava AM, Sugihara K, Katumata K (1991) Preservation of urine voiding and sexual function after rectal-cancer surgery. Dis Colon Rectum 34:532–539CrossRefPubMed
21.
go back to reference van Gijn W, Marijnen CAM, Nagtegaal ID, Kranenbarg EMK, Putter H, Wiggers T et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–582CrossRefPubMed van Gijn W, Marijnen CAM, Nagtegaal ID, Kranenbarg EMK, Putter H, Wiggers T et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–582CrossRefPubMed
22.
go back to reference Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, Kinugasa Y et al (2016) Male sexual dysfunction after rectal cancer surgery: results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Ejso 42:1851–1858CrossRefPubMed Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, Kinugasa Y et al (2016) Male sexual dysfunction after rectal cancer surgery: results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Ejso 42:1851–1858CrossRefPubMed
Metadata
Title
Lateral Lymph Node Dissection Was Unnecessary for Low and Middle Rectal Cancer: a Systematic Review and Meta-analysis
Authors
Jiajie Zhou
Xiaoming Yuan
Publication date
05-12-2022
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue 5/2023
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-022-03632-9

Other articles of this Issue 5/2023

Indian Journal of Surgery 5/2023 Go to the issue